ArticleJACC. Case reports2025
Recurrent Right Atrial Thrombus After Percutaneous ASD Closure.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPercutaneous device closure is the preferred approach for closing secundum atrial septal defects (ASDs), offering a minimally invasive alternative to surgery. Although generally safe, device-related thrombus formation is a rare but serious complication, with limited evidence guiding diagnosis and management. CASE SUMMARY: We present a case of a 35-year-old woman who underwent percutaneous device closure of a secundum ASD. She developed intermittent fevers within 48 hours postprocedure, though initial work-up was negative. Three months later, a routine transthoracic echocardiogram revealed a mobile mass attached to the ASD device. She underwent AngioVac thrombectomy, but recurrence of thrombus required surgical removal of the device and ASD patch closure. DISCUSSION: This case highlights a rare but serious complication of ASD device closure, underscoring the importance of vigilant follow-up and individualized antithrombotic strategies. TAKE-HOME MESSAGES: Recurrent thrombus formation after ASD device closure is rare but may necessitate surgical intervention in high-risk patients. Individualized risk assessment, including prothrombotic states and residual shunting, should guide postprocedural antithrombotic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.